Table 3; online.
Incidence of vasopressor use for at least 24 hours during days 4–7 | ||||||
---|---|---|---|---|---|---|
≤256/7 weeks gestation (n=130) | ≥26 weeks gestation (n=183) | |||||
Vasopressor | Conservative epoch (n=41) |
Prophylactic epoch (n=89) |
p-value | Conservative epoch (n=57) |
Prophylactic epoch epoch |
p-value |
% | % | % | % | |||
Dopamine -any | 37 | 22 | 0.09 | 21 | 15 | 0.32 |
Dopamine ≥6 µg/kg/min | 32 | 13 | 0.01 | 14 | 9 | 0.28 |
Dopamine ≥10 µg/kg/min | 22 | 9 | 0.04 | 14 | 4 | 0.01 |
Hydrocortisone * | 5 | 2 | 0.65 | 7 | 1 | 0.03 |
Incidence of hydrocortisone use when dopamine infusion rate ≥16 µg/kg/min